Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MR Imaging-Guided Focused Ultrasound for Breast Tumors.
DeWitt M, Demir ZEF, Sherlock T, Brenin DR, Sheybani ND. DeWitt M, et al. Among authors: sheybani nd. Magn Reson Imaging Clin N Am. 2024 Nov;32(4):593-613. doi: 10.1016/j.mric.2024.04.004. Epub 2024 May 16. Magn Reson Imaging Clin N Am. 2024. PMID: 39322350 Review.
AI Transformers for Radiation Dose Reduction in Serial Whole-Body PET Scans.
Wang YJ, Qu L, Sheybani ND, Luo X, Wang J, Hawk KE, Theruvath AJ, Gatidis S, Xiao X, Pribnow A, Rubin D, Daldrup-Link HE. Wang YJ, et al. Among authors: sheybani nd. Radiol Artif Intell. 2023 May 3;5(3):e220246. doi: 10.1148/ryai.220246. eCollection 2023 May. Radiol Artif Intell. 2023. PMID: 37293349 Free PMC article.
Barriers to immune cell infiltration in tumors.
Melssen MM, Sheybani ND, Leick KM, Slingluff CL Jr. Melssen MM, et al. Among authors: sheybani nd. J Immunother Cancer. 2023 Apr;11(4):e006401. doi: 10.1136/jitc-2022-006401. J Immunother Cancer. 2023. PMID: 37072352 Free PMC article. Review.
Solid Tumor Treatment via Augmentation of Bioactive C6 Ceramide Levels with Thermally Ablative Focused Ultrasound.
Thim EA, Fox T, Deering T, Vass LR, Sheybani ND, Kester M, Price RJ. Thim EA, et al. Among authors: sheybani nd. bioRxiv [Preprint]. 2023 Mar 23:2023.03.23.532394. doi: 10.1101/2023.03.23.532394. bioRxiv. 2023. Update in: Drug Deliv Transl Res. 2023 Dec;13(12):3145-3153. doi: 10.1007/s13346-023-01377-w PMID: 36993445 Free PMC article. Updated. Preprint.
Low-count whole-body PET/MRI restoration: an evaluation of dose reduction spectrum and five state-of-the-art artificial intelligence models.
Wang YJ, Wang P, Adams LC, Sheybani ND, Qu L, Sarrami AH, Theruvath AJ, Gatidis S, Ho T, Zhou Q, Pribnow A, Thakor AS, Rubin D, Daldrup-Link HE. Wang YJ, et al. Among authors: sheybani nd. Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1337-1350. doi: 10.1007/s00259-022-06097-w. Epub 2023 Jan 12. Eur J Nucl Med Mol Imaging. 2023. PMID: 36633614 Free PMC article.
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
Sworder BJ, Kurtz DM, Alig SK, Frank MJ, Shukla N, Garofalo A, Macaulay CW, Shahrokh Esfahani M, Olsen MN, Hamilton J, Hosoya H, Hamilton M, Spiegel JY, Baird JH, Sugio T, Carleton M, Craig AFM, Younes SF, Sahaf B, Sheybani ND, Schroers-Martin JG, Liu CL, Oak JS, Jin MC, Beygi S, Hüttmann A, Hanoun C, Dührsen U, Westin JR, Khodadoust MS, Natkunam Y, Majzner RG, Mackall CL, Diehn M, Miklos DB, Alizadeh AA. Sworder BJ, et al. Among authors: sheybani nd. Cancer Cell. 2023 Jan 9;41(1):210-225.e5. doi: 10.1016/j.ccell.2022.12.005. Epub 2022 Dec 29. Cancer Cell. 2023. PMID: 36584673 Free PMC article.
Applications of focused ultrasound-mediated blood-brain barrier opening.
Gorick CM, Breza VR, Nowak KM, Cheng VWT, Fisher DG, Debski AC, Hoch MR, Demir ZEF, Tran NM, Schwartz MR, Sheybani ND, Price RJ. Gorick CM, et al. Among authors: sheybani nd. Adv Drug Deliv Rev. 2022 Dec;191:114583. doi: 10.1016/j.addr.2022.114583. Epub 2022 Oct 19. Adv Drug Deliv Rev. 2022. PMID: 36272635 Free PMC article. Review.
25 results